Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Relevance of Biological Subtype Overrides That of TNM Staging in Breast Cancer: Discordance Between Stage and Biology

NCT02063906 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02063906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02063906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Relevance of Biological Subtype Overrides That of TNM Staging in Breast Cancer: Discordance Between Stage and Biology
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2014
Completion date
May 31, 2019
Enrollment
202 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer